Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BBNXBSX

Beta Bionics, Inc.

BBNX · $19.16

62Good

Boston Scientific Corporation

BSX · $45.05

67Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BBNX

62/100

BSX

67/100

Quality

Is it a profitable, well-run business?

BBNX

2.0/10

BSX

5.5/10

Growth

Is the company growing?

BBNX

7.3/10

BSX

6.6/10

Valuation

Is the price reasonable? (higher = cheaper)

BBNX

0.0/10

BSX

9.2/10

Risk

How risky are the shares? (higher = lower risk)

BBNX

2.2/10

BSX

4.9/10

Momentum

Is the share price trending up?

BBNX

9.3/10

BSX

6.0/10

Financial strength

Is the balance sheet healthy?

BBNX

7.5/10

BSX

5.8/10

The balanced view

Model-generated

Beta Bionics, Inc.

This company scores above average, with a positive price trend and a healthy balance sheet, although its current valuation deserves attention.

Leads on: growth, momentum, financial strength

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: valuation may be demanding (P/E (TTM): -11.4x)

Boston Scientific Corporation

This company scores above average, with a reasonable valuation and solid growth.

Leads on: quality, valuation, risk

Best feature: reasonable valuation (PEG: 0.40)

Watch out: weakest area: risk profile (Largest 1Y drawdown: -60%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.